Back HIV Prevention Pre-exposure (PrEP)

Pre-exposure Prophylaxis (PrEP)

France Approves Truvada for HIV Pre-exposure Prophylaxis

In a historic move, France has become the first country outside the U.S., and the first country with a centrally organized, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it. The French Minister of Health, Marisol Touraine, announced on November 24 today that PrEP would be available starting in mid-December, and reimbursable through the French health system from the beginning of January.

alt

Read more:

EACS 2015: Barcelona Clinic Study Counts How Many Gay Men Might Benefit from PrEP

A study from the Barcelona Checkpoint gay men’s HIV clinic, presented at the recent 15th European AIDS Conference, has found a strong and consistent relationship between the annual HIV infection rate (incidence) of different categories of clinic users and the particular combination of risk factors they self-report. The primary intention behind this study was to estimate what proportion of clinic users might benefit from HIV pre-exposure prophylaxis (PrEP). In doing the exercise, however, the clinic also managed to establish interesting new estimates for the relative contribution to HIV risk of condomless sex, sexually transmitted infections, high sex partner numbers, and sexual role.

alt

Read more:

Truvada PrEP Appears to Work for Transgender Women, But Only If Used Consistently

The more than 300 transgender women in the pivotal iPrEx pre-exposure prophylaxis (PrEP) trial had similar overall HIV infection rates whether they were randomized to take Truvada or placebo, but those with drug levels indicating consistent PrEP use appeared to be protected, researchers reported in the November 5 advance online edition of The Lancet.

alt

Read more:

How Do We Maximize HIV Treatment Access? IAPAC Care Continuum Guidelines Make Recommendations

IAPAC, the International Association of Practitioners in AIDS Care, has issued a set of guidelines that aims to establish a common set of best practices to ensure that as many people living with HIV as possible are diagnosed, cared for, receive treatment, and achieve undetectable viral loads.

alt

Read more:

EACS 2015: When Will Europe Get PrEP?

Pressure is mounting at the community level for access to pre-exposure prophylaxis (PrEP) in Europe and is likely to continue to increase in the absence of decisions by funding authorities and regulators, leading to more informal use, speakers said at the 15th European AIDS Conference this week in Barcelona. At the moment, PrEP is not being funded by national or regional governments in Europe, and any use that is occurring is either the result of individual arrangements with doctors, private prescribing outside the public health systems, or informal and unmonitored use.

alt

 

Read more: